| HOME >> BIOLOGY >> TECHNOLOGY |
WEST LAFAYETTE, Ind. - Understanding precisely how fluid boils in tiny "microchannels" has led to formulas and models that will help engineers design systems to cool high-power electronics in electric and hybrid cars, aircraft, computers and other devices.
Allowing a liquid to boil in cooling systems dramatically increases how much heat can be removed, compared to simply heating a liquid to below its boiling point, said Suresh Garimella, the R. Eugene and Susie E. Goodson Professor of Mechanical Engineering at Purdue University.
However, boiling occurs differently in tiny channels than it does in ordinary size tubing used in conventional cooling systems.
"One big question has always been, where is the transition from macroscale boiling to microscale boiling?" said doctoral student Tannaz Harirchian. "How do you define a microchannel versus a macrochannel, and at what point do we need to apply different models to design systems? Now we have an answer."
Findings will be detailed in a research paper by Garimella and Harirchian and a keynote address to be presented by Garimella on Oct. 8 during the conference Thermal Investigations of ICs and Systems, or Therminic, from Oct. 7-9 in Leuven, Belgium. The researchers also have published several related papers in peer-reviewed journals.
Indiana's 21st Century Research and Technology Fund has provided $1.9 million to Purdue and Delphi Corp. in Kokomo, Ind., to help commercialize the advanced cooling system using microchannels for electronic components in hybrid and electric cars. The research also is funded by the Purdue-based National Science Foundation Cooling Technologies Research Center, a consortium of corporations, university and government laboratories working to overcome heat-transfer obstacles in developing new compact cooling technologies.
The new type of cooling system will be used to prevent overheating of devices called insulated gate bipolar
'/>"/>
| Contact: Emil Venere venere@purdue.edu 765-494-4709 Purdue University Source:Eurekalert |
Related biology technology :
1. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
2. Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in Schizophrenia to be Postered at the 20th Annual U.S. Psychiatric and Mental Health Congress
3. Clinical Study Findings Show Safety and Procedure Success for TopSpin IntraVascular MRI Catheter for the Coronary Arteries
4. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
5. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
6. WHI Findings Published in JAMA Do Not Affect Clinical Guidance for the Appropriate Use of Hormone Therapy
7. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
8. ARIUS presents new findings for anti-cancer antibody programs at AACR
9. Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research
10. Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040
11. Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings
 |
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |